Open AccessEplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Author(s) -
Faı̈ez Zannad,
John J.V. McMurray,
Henry Krum,
Dirk J. van Veldhuisen,
Karl Swedberg,
Harry Shi,
John Vincent,
Stuart J. Pocock,
Bertram Pitt
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1009492
Subject(s) - eplerenone , medicine , heart failure , cardiology , myocardial infarction , spironolactone , aldosterone , mineralocorticoid , mineralocorticoid receptor
Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart failure after myocardial infarction. We evaluated the effects of eplerenone in patients with chronic systolic heart failure and mild symptoms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom